SCHEMBL16017252

SCHEMBL16017252

Cc1oc(-c2ccccc2)cc1C(=O)Nc1ccc(-c2cc(C(F)(F)F)nn2C)c(F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
HPGD P15428 3/20 0.52
CYP1A2 P05177 2/20 0.52
ALOX12 P18054 1/20 0.52
MAPT P10636 4/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
POLB P06746 1/20 0.44
DGAT1 O75907 2/20 0.43
LMNA P02545 1/20 0.43
CRACR2A Q9BSW2 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
THRB P10828 1/20 0.42
S1PR1 P21453 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14887705 0.83 CRACR2A (0.58) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL14887485 0.83 CRACR2A (0.49) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL16017173 0.82 DGAT1 (0.45) ALDH1A1MAPTPOLBDGAT1CRACR2A
SCHEMBL14887329 0.81 CRACR2A (0.60) CYP1A2CYP3A4CYP2C9CYP2C19POLB
SCHEMBL16017200 0.80 CRACR2A (0.44) ALDH1A1CYP1A2CYP3A4CYP2C19POLB
SCHEMBL16017245 0.80 HDAC3 (0.44) ALDH1A1MAPTCYP3A4POLBCRACR2A
SCHEMBL16017182 0.79 BACE1 (0.44) ALDH1A1KMT2ACYP3A4POLBCRACR2A
SCHEMBL16019789 0.79 POLB (0.43) ALDH1A1CYP3A4POLBCRACR2A
SCHEMBL14881306 0.79 CRACR2A (0.47) ALDH1A1MAPTCYP3A4CRACR2ASMN1; SMN2
SCHEMBL18038397 0.78 CRACR2A (0.46) ALDH1A1CYP3A4POLBCRACR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 US disclosed
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 ALDH1A1 4409/4885MEN1 2958/4885KMT2A 4706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.